Evidence map›Paper›PMID 30588791›Full record

ArticleACS applied materials & interfaces2019

Design, Synthesis, and Nanostructure-Dependent Antibacterial Activity of Cationic Peptide Amphiphiles.

Nathalia Rodrigues de Almeida, Yuchun Han, Jesus Perez, Sydney Kirkpatrick, Yilin Wang, Martin Conda Sheridan

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 133 citations in OpenAlex.

  1. Review
  2. Nanostructure and Collagen-Stimulating Activity of Cationic Pentapeptide Lipopeptides.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Engineering a nanoantibiotic system displaying dual mechanism of action.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Peptides as carriers of active ingredients: A review.Current research in food science · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nathalia Rodrigues de AlmeidaDepartment of Pharmaceutical Sciences , College of Pharmacy, University of Nebraska Medical Center , Omaha , Nebraska 68198 , United States.ORCID http://orcid.org/0000-0002-9552-1233
Yuchun HanKey Laboratory of Colloid and Interface Science, Beijing National Laboratory for Molecular Sciences (BNLMS) , Institute of Chemistry, Chinese Academy of Sciences , Beijing 100190 , People's Republic of China.ORCID http://orcid.org/0000-0002-2928-2633
Jesus Perez
Sydney Kirkpatrick
Yilin WangKey Laboratory of Colloid and Interface Science, Beijing National Laboratory for Molecular Sciences (BNLMS) , Institute of Chemistry, Chinese Academy of Sciences , Beijing 100190 , People's Republic of China.ORCID http://orcid.org/0000-0002-8455-390X
Martin Conda SheridanDepartment of Pharmaceutical Sciences , College of Pharmacy, University of Nebraska Medical Center , Omaha , Nebraska 68198 , United States.ORCID http://orcid.org/0000-0002-3568-2545
Chinese Academy of Sciences · CNCreighton University · USNebraska Medical Center · US

Funding

Project 9 - Renal Drug Targeting for the Treatment of Lupus NephritisP20GM103480 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BRONICH, TATIANA K · 2012 to 2017
$13.3M
Nebraska Center for Nanomedicine- Pilot ProjectsP30GM127200 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BRONICH, TATIANA K · 2018 to 2022
$5.7M
NIGMS NIH HHS P20 GM103480
6 · The paper itself

Abstract

The development of bacterial resistant strains is a global health concern. Designing antibiotics that limit the rise of pathogenic resistance is essential to efficiently treat pathogenic infections. Self-assembling amphiphilic molecules are an intriguing platform for the treatment of pathogens because of their ability to disrupt bacterial membranes and function as drug nanocarriers. We have designed cationic peptide amphiphiles (PAs) that can form micelles, nanofibers, and twisted ribbons with the aim of understanding antimicrobial activity at the supramolecular level. We have found that micelle-forming PAs possess excellent antimicrobial activity against various Gram-positive and Gram-negative pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Klebsiella pneumoniae with minimal inhibitory concentrations (MICs) ranging between 1 and 8 μg/mL, when compared to nanofibers with MICs >32 μg/mL. The data suggest that the antimicrobial activity of the PAs depends on their morphology, amino acid sequence, the length of the alkyl tail, and the overall hydrophobicity of the PA. Scanning electron microscopy, confocal microscopy, and flow cytometry studies using MRSA and Escherichia coli K12 strains showed that PAs increase cell membrane permeability and disrupt the integrity of pathogen's membrane, leading to cell lysis and death. PAs are a promising platform to develop new antimicrobials that could work as nanocarriers to develop synergistic antibacterial therapies.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial InfectionsCell Membrane PermeabilityDrug CarriersEscherichia coliHumansKlebsiella pneumoniaeMethicillin-Resistant Staphylococcus aureusMicroscopy, Electron, ScanningNanofibersNanostructuresAnti-Bacterial AgentsAntimicrobial Cationic PeptidesDrug Carriersantimicrobialscationic nanostructuresmicellespeptide amphiphilesself-assemblysupramolecular structure-activity relationships

Identifiers

PMID30588791
PMCPMC7199185
OpenAlexW2907945052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.